Latest Articles

Gastrointestinal Cancers

Malignant Gastric Outlet Obstruction

Malignant Gastric Outlet Obstruction

Common gastrointestinal symptoms experienced by patients with cancer can vary widely and determining an underlying malignancy can prove difficult.

General Oncology CD151—A Striking Marker for Cancer Therapy

CD151—A Striking Marker for Cancer Therapy

[Biomarkers in Cancer] Cluster of differentiation 151 (CD151) functions at various stages of cancer, including metastatic cascade and primary tumor growth, reinforcing the importance of CD151 as a target in oncology.

General Oncology Multigene Cancer-Susceptibility Tests Require New Approaches to Patient Counseling

Multigene Cancer-Susceptibility Tests Require New Approaches to Patient Counseling

Multigene panel technology is gaining favor, but tests are outpacing the molecular-epidemiological evidence base and models for patient counseling.

Gastrointestinal Cancers Do Patients with Locally Advanced Rectal Cancer Benefit from Adjuvant Chemotherapy?

Do Patients with Locally Advanced Rectal Cancer Benefit from Adjuvant Chemotherapy?

A recent letter in JCO discusses whether patients with locally advanced rectal cancer need adjuvant chemotherapy.

Breast Cancer Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

[Breast Cancer: Targets and Therapy] This review focuses on the role of the WASP/WAVE family in breast cancer cell invasion and migration.

General Oncology The Power of Placebo in Aromatase Inhibitor-Induced Arthralgia

The Power of Placebo in Aromatase Inhibitor-Induced Arthralgia

Researcher found an improvement in aromatase inhibitor-associated arthralgia in both omega-3 fatty acids and placebo treatment.

Pancreatic Cancer Stereotactic Body Radiotherapy Using Fiducial Implants for Pancreatic Cancer

Stereotactic Body Radiotherapy Using Fiducial Implants for Pancreatic Cancer

New treatment modalities are being developed for patients with pancreatic cancer aimed at improving efficacy as well as limiting toxicity.

Gastrointestinal Cancers Next-Generation Sequencing Panels Cost-Effective for Diagnosis of Hereditary Colorectal Cancer

Next-Generation Sequencing Panels Cost-Effective for Diagnosis of Hereditary Colorectal Cancer

A decision model finds that the higher cost of new sequencing methods is justified by their clinical benefits.

Pancreatic Cancer Vitamin D Levels and Risk for Pancreatic Cancer

Vitamin D Levels and Risk for Pancreatic Cancer

Recent reports indicate a potential association between sunlight exposure and risk of pancreatic cancer.

Breast Cancer The 1%: Unraveling What Drives Breast Cancer in Males

The 1%: Unraveling What Drives Breast Cancer in Males

While research on breast cancer in men is growing, more is needed to offer the best treatment options to this subset of patients.

Palliative Care Threading the cloak: palliative care education for care providers of adolescents, young adults with cancer

Threading the cloak: palliative care education for care providers of adolescents, young adults with cancer

[Clinical Oncology in Adolescents and Young Adults] Integration of palliative care at the time of diagnosis enables a supportive partnership with the medical team.

Urologic Cancers New Genetic Sequencing May Lead to Urine Test for Bladder Cancer

New Genetic Sequencing May Lead to Urine Test for Bladder Cancer

Early research indicates the possibility for a urine test for bladder cancer.

Prostate Cancer Lethal Metastatic Prostate Cancer May Spread from Other Sites

Lethal Metastatic Prostate Cancer May Spread from Other Sites

New research indicates that prostate cancer metastasis may spread from multiple tumor clones.

General Oncology Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Lymphoma ABVD, Radiotherapy vs. Stanford V in Stage 1/2 Bulky Hodgkin Lymphoma

ABVD, Radiotherapy vs. Stanford V in Stage 1/2 Bulky Hodgkin Lymphoma

ABVD and Stanford V treatment regimens show similar efficacy in patients with Hodgkin lymphoma.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs